Clinical Trials Logo

Threatened Abortion clinical trials

View clinical trials related to Threatened Abortion.

Filter by:
  • None
  • Page 1

NCT ID: NCT04788108 Completed - Threatened Abortion Clinical Trials

Oral Progesterone for Prevention of Miscarriage in Threatened Abortion

Start date: August 1, 2021
Phase: Phase 4
Study type: Interventional

This study evaluates the effectiveness of oral dydrogesterone in preventing miscarriage in threatened abortion. Half of participants will receive oral dydrogesterone, while the other half will receive oral placebo.

NCT ID: NCT03930212 Completed - Clinical trials for Progesterone Resistance

Progesterone Supplementation in Threatened Abortion

Prothreat
Start date: January 1, 2018
Phase: Phase 4
Study type: Interventional

To decide whether progesterone supplementation in threatened abortion is a sound practice.

NCT ID: NCT02686112 Completed - Threatened Abortion Clinical Trials

Pregnancy Outcome in Woman With Threatened Abortion

POTA
Start date: January 2007
Phase: N/A
Study type: Observational

The study aims to quantify the relations between first & second trimester bleeding and maternal & neonatal morbidity. Additionally, the study will help in assessing the risk for abortions in women with threatened abortions and the risk factors for threatened abortion.

NCT ID: NCT02420769 Completed - Threatened Abortion Clinical Trials

Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion

CLCA125
Start date: September 2014
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether assessing color doppler of corpus luteum and uterine artery is useful in predicting patients who will complete pregnancy. The investigators will add to this the usefulness of serum progesterone and CA125 in prediction.

NCT ID: NCT01501890 Withdrawn - Premature Birth Clinical Trials

Progesterone for First Trimester Vaginal Bleeding

Start date: January 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether treatment with progesterone for patients with first trimester vaginal bleeding will alter the rates of obstetrical complications and adverse pregnancy outcomes.